Objectives: To determine the prevalence of premenstrual symptoms (PMS) due to primary dysmenorrhea among a sample of university female students, and to explore possible association with vitamin D and parathyroid (PTH) levels, as well as frequency of consumption of dairy products. Design: A cross-sectional study. Setting: One Jordanian university. Subjects: A total of 177 female students aged between 18 and 24 years who experienced primary dysmenorrhea participated in the study and completed a self administered questionnaire to collect information concerning demographics, menstruation- related information, associated specified premenstrual symptoms, and consumption of dairy products. Plasma 25-hydroxyvitamin vitamin D level and intact parathyroid hormone level were measured. Results: Of the 177 participants 91.5% had two or more symptoms among which fatigue, mood swings, anxiety, abdominal bloating, and depression were the most prevalent symptoms. There was no evident association between presence of symptoms and vitamin D status, PTH level or dairy products consumption. Headaches and social withdrawal were significantly lower in those women who consumed high amounts of dairy products. Conclusion : Premenstrual symptoms are very common in young women with primary dysmenorrhea. PMS has no relation to levels of vitamin D, parathyroid hormone or dairy products consumption. Headache and social withdrawal may be affected by dairy product consumption.
References
[1]
French, L. Dysmenorrhea. Am. Fam. Physician 2005, 71, 285–291.
[2]
Latthe, P.; Latthe, M.; Say, L.; Gülmezoglu, M.; Khan, KS. WHO systematic review of prevalence of chronic pelvic pain: A neglected reproductive health morbidity. BMC Publ. Health 2006, 177, doi:10.1186/1471-2458-6-177.
[3]
Harlow, SD.; Campbell, O.M.R. Epidemiology of menstrual disorders in developing countries: A systematic review. BJOG 2004, 111, 6–16, doi:10.1111/j.1471-0528.2004.00012.x.
[4]
Tabassum, S.; Afridi, B.; Aman, Z.; Tabassum, W.; Durrani, R. Premenstrual syndrome: Frequency and severity in young college girls. J. Pak. Med. Assoc. 2005, 55, 546–549.
[5]
Pinar, G.; Colak, M.; Oksuz, E. Premenstrual syndrome in Turkish college students and its effects on life quality. Sex Reprod. Healthc. 2011, 2, 21–27, doi:10.1016/j.srhc.2010.10.001.
[6]
Harel, Z. Dysmenorrhea in adolescents and young adults: Etiology and management. J. Pediatr. Adolesc. Gynecol. 2006, 19, 363–371, doi:10.1016/j.jpag.2006.09.001.
[7]
Freeman, E.W. Premenstrual syndrome and premenstrual dysphoric disorder: Definitions and diagnosis. Psychoneuroendocrinology 2003, 28, S25–S37, doi:10.1016/S0306-4530(03)00099-4.
[8]
Hart, W.G.; Coleman, G.J.; Russell, J.W. Assessment of premenstrual symptomatology: A re-evaluation of the predictive validity of self-report. J. Psychosom. Res. 1987, 31, 185–190, doi:10.1016/0022-3999(87)90075-4.
[9]
Futterman, L.A.; Rapkin, A.J. Diagnosis of premenstrual disorders. J. Reprod. Med. 2006, 51, S349–S358.
[10]
Bertone-Johnson, E.R.; Hankinson, S.E.; Johnson, S.R.; Manson, J.E. A simple method of assessing premenstrual syndrome in large prospective studies. J. Reprod. Med. 2007, 52, 779–786.
[11]
Limosin, F.; Ades, J. Psychiatric and psychological aspects of premenstrual syndrome. Encephale 2001, 27, 501–508.
[12]
Reddish, S. Dysmenorrhea. Aust. Fam. Physician 2006, 35, 842–849.
Inoue, Y.; Terao, T.; Iwata, N.; Okamoto, K.; Kojima, H.; Okamoto, T.; Yoshimura, R.; Nakamura, J. Fluctuating serotonergic function in premenstrual dysphoric disorder and premenstrual syndrome: Findings from neuroendocrine challenge tests. Psychopharmacology (Berl.) 2007, 190, 213–219.
[19]
Issa, B.A.; Yussuf, A.D.; Olatinwo, A.W.; Ighodalo, M. Premenstrual dysphoric disorder among medical students of a Nigerian university. Ann. Afr. Med. 2010, 9, 118–122, doi:10.4103/1596-3519.68354.
[20]
Fujiwara, T.; Nakata, R. Young Japanese college students with dysmenorrhea have high frequency of irregular menstruation and premenstrual symptoms. Open Med. Inform. J. 2007, 1, 8–11, doi:10.2174/1874431100701010008.
[21]
Barnard, N.D.; Scialli, A.R.; Hurlock, D.; Bertron, P. Diet and sex-hormone binding globulin, dysmenorrhea, and premenstrual symptoms. Obstet. Gynecol. 2000, 95, 245–250, doi:10.1016/S0029-7844(99)00525-6.
[22]
Marsden, J.S.; Strickland, C.D.; Clements, M.T.L. Guanafensin as a treatment for primary dysmenorrheal. J. Am. Board Fam. Pract. 2004, 17, 240–246, doi:10.3122/jabfm.17.4.240.
[23]
Eccles, R.; Holbrook, A.; Jawad, M. A double-blind, randomised, crossover study of two doses of a single-tablet combination of ibuprofen/paracetamol and placebo for primary dysmenorrhoea. Curr. Med. Res. Opin. 2010, 26, 2689–2699, doi:10.1185/03007995.2010.525028.
[24]
Abdul-Razzak, K.K.; Ayoub, N.M.; Abu-Taleb, A.A.; Obeidat, B.A. The influence of dietary intake of dairy products on dysmenorrhea. J. Obstet. Gynaecol. Res. 2010, 36, 377–383, doi:10.1111/j.1447-0756.2009.01159.x.
[25]
Bertone-Johnson, E.R.; Chocano-Bedoya, P.O.; Zagarins, S.E.; Micka, A.E.; Ronnenberg, A.G. Dietary vitamin D intake, 25-hydroxyvitamin D3 levels and premenstrual syndrome in a college-aged population. J. Steroid. Biochem. Mol. Biol. 2010, 121, 434–437, doi:10.1016/j.jsbmb.2010.03.076.
[26]
Mortola, J.F.; Girton, L.; Beck, L.; Yen, S.S. Diagnosis of premenstrual syndrome by a simple, prospective, and reliable instrument: The calendar of premenstrual experiences. Obstet. Gynecol. 1990, 76, 302–307.
[27]
Thys-Jacobs, S. Micronutrients and the premenstrual syndrome: The case for calcium. J. Am. Coll. Nutr. 2000, 19, 220–227.
[28]
Penland, J.G.; Johnson, P.E. Dietary calcium and manganese effects on menstrual cycle symptoms. Am. J. Obstet. Gynecol. 1993, 168, 1417–1423.
[29]
Thys-Jacobs, S.; Starkey, P.; Bernstein, D.; Tian, J. Calcium carbonate and the premenstrual syndrome: Effects on premenstrual and menstrual symptoms. Premenstrual Syndrome Study Group. Am. J. Obstet. Gynecol. 1998, 179, 444–452, doi:10.1016/S0002-9378(98)70377-1.
[30]
Bertone-Johnson, E.R. Vitamin D and the occurrence of depression: Causal association or circumstantial evidence? Nutr. Rev. 2009, 67, 481–492, doi:10.1111/j.1753-4887.2009.00220.x.
[31]
Khajehei, M.; Abdali, K.; Parsanezhad, M.E.; Tabatabaee, H.R. Effect of treatment with dydrogesterone or calcium plus vitamin D on the severity of premenstrual syndrome. J. Gynaecol. Obstet. 2009, 105, 158–161.
[32]
Thys-Jacobs, S.; McMahon, D.; Bilezikian, J.P. Cyclical changes in calcium metabolism across the menstrual cycle in women with premenstrual dysphoric disorder. J. Clin. Endocrinol. Metab. 2007, 92, 2952–2959, doi:10.1210/jc.2006-2726.
[33]
Thys-Jacobs, S.; Alvir, M.J. Calcium-regulating hormones across the menstrual cycle: Evidence of a secondary hyperparathyroidism in women with PMS. J. Clin. Endocrinol. Metab. 1995, 80, 2227–2232, doi:10.1210/jc.80.7.2227.
